Zilico
Developer of a cervical cancer diagnostic system.
Launch date
Employees
Market cap
-
Enterprise valuation
€69—104m (Dealroom.co estimates Feb 2018.)
Company register number 05724284
Manchester England (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | 75 % | (2 %) | (67 %) | 149 % | (73 %) | 79 % | (6 %) |
| EBITDA | (1.3m) | (2.1m) | (2.8m) | (1.4m) | (1.5m) | (1.8m) | - |
| % EBITDA margin | (850 %) | (1336 %) | (5453 %) | (1105 %) | (4570 %) | (2996 %) | - |
| Profit | (1.6m) | (2.3m) | (2.9m) | (1.6m) | (1.5m) | (1.9m) | - |
| % profit margin | (1019 %) | (1469 %) | (5682 %) | (1216 %) | (4479 %) | (3095 %) | - |
| R&D budget | <1m | <1m | <1m | - | - | - | - |
| R&D % of revenue | 64 % | 65 % | 585 % | - | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
£990k | Seed | ||
N/A | - | ||
| N/A | £750k | Seed | |
| N/A | N/A | Seed | |
$1.8m | Series A | ||
| N/A | N/A | Seed | |
* | $19.0m | Late VC | |
* | £884k | Grant | |
N/A | Growth Equity VC | ||
| Total Funding | €22.1m | ||
Related Content
Recent News about Zilico
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.